Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Research Article

Measurement Uncertainty and Validation for Quantification of Marijuana Metabolite: (−)-11-nor-9-Carboxy-Δ9-THC in Human Urine by GC-MS/MS

Author(s): Ashok Kumar Maurya, Puran Lal Sahu and Kapendra Sahu*

Volume 20, Issue 9, 2024

Published on: 24 October, 2024

Page: [1056 - 1065] Pages: 10

DOI: 10.2174/0115734129347983241023100539

Price: $65

Abstract

Background: Since the International Olympic Committee (IOC) was established, sports doping control analyses have revealed a high rate of positive cases for cannabinoids. Cannabinoids were banned in all sports where they were used in-competition as per the Prohibited List published annually. Further, it was also included in the threshold drug category. Consequently, developing a reliable method for urine Cannabinoids metabolite quantification plays a pivotal role in sports dope testing.

Objectives: This work aimed to develop and validate a reliable, cost-effective, robust gas chromatography-tandem mass spectrometry method for detecting (−)-11-nor-9-Carboxy-Δ9- THC component in human urine samples, in compliance with ICH and WADA guidelines.

Methods: The sample preparation was done by enzymatic hydrolysis for deconjugation, further proceeded with solid phase extraction (SPE), liquid-liquid extraction (LLE), and using an XAD2 column, and N-methyl trimethylsilyl trifluoroacetamide (MSTFA) for derivatization.

Results: The linearity was obtained in a range of 50–300 ng/mL, and the correlation coefficient was found to be higher than 0.99. Throughout the entire validation study, the difference in Retention Time (RT) for the analyte, including the Internal Standard (IS), was shown to be less than 1.0%. The quantification limit (LOQ) was calculated at a level of 50 ng/mL in human urine samples for the 3 most abundant ion transitions. The detection limit (LOD) was established at 4 ng/mL.

Conclusion: The accuracy, precision, linearity, recovery, quantification limit, and selectivity by GC-MS/MS technique were found acceptable and well satisfactory while following the ICH guidelines. The developed method has been proven to be fit for purpose in accordance with the enforced Guidelines of WADA.

Keywords: Cannabinoids, (−)-11-nor-9-Carboxy-Δ9-THC, validation, ICH guidelines, GC-MS/MS, doping control, human urine, WADA.

Graphical Abstract
[1]
Moffad, A.C.; Osselton, M.D.; Widdop, B. Clarke’s Analysis of Drugs and Poisons, 3rd ed; Pharmaceutical Press: London, 1990.
[2]
Huestis, M.A. 2002. Available from: http://137.187.144.24/endnote_pdfs/rm-008540.pdf (accessed on 8-10-2024)
[3]
a) Moffat, A.C. The legalisation of Cannabis for medical use. Sci. Justice J. Forensic Sci. Soc., 2002, 42(1), 55-57.;
b) Brenneisen, R. Determination of the major Δ9-tetrahydrocannabinol metabolite in urine by high-performance liquid chromatography and photodiode array detection. Anal. Chim. Acta, 1987, 198, 183-189.
[http://dx.doi.org/10.1016/S0003-2670(00)85018-7]
[4]
Lendoiro, E.; de Castro, A.; Vega, H.; Pérez, M.C.; Vilariño, J.M.; Rodríguez, M.V.; Cruz, A.; Rivadulla, M. Molecularly imprinted polymer for selective determination of Δ9-tetrahydrocannabinol and 11-nor-Δ9-tetrahydrocannabinol carboxylic acid using LC-MS/MS in urine and oral fluid. Anal. Bioanal. Chem., 2014, 406(15), 3589-3597.
[http://dx.doi.org/10.1007/s00216-013-7599-1] [PMID: 24429976]
[5]
Montesano, C.; Sergi, M.; Odoardi, S.; Simeoni, M.C.; Compagnone, D.; Curini, R. A μ-SPE procedure for the determination of cannabinoids and their metabolites in urine by LC–MS/MS. J. Pharm. Biomed. Anal., 2014, 91, 169-175.
[http://dx.doi.org/10.1016/j.jpba.2013.12.035] [PMID: 24469020]
[6]
Shannon, E.; Havill, J. Creating creatinine: How to pass a urine drug test. Nephrol. Open J., 2023, 7(1), 1-3.
[http://dx.doi.org/10.17140/NPOJ-7-126]
[7]
Scholz, C.; Madry, M.M.; Kraemer, T.; Baumgartner, M.R. LC–MS-MS analysis of Δ9-THC, CBN and CBD in Hair: Investigation of artifacts. J. Anal. Toxicol., 2022, 46(5), 504-511.
[http://dx.doi.org/10.1093/jat/bkab056] [PMID: 34041537]
[8]
Childs, P.S.; McCurdy, H.H. Evaluation of a radioimmunoassay (125I) kit for cannabinoid metabolites in urine and whole blood. J. Anal. Toxicol., 1984, 8(5), 220-223.
[http://dx.doi.org/10.1093/jat/8.5.220] [PMID: 6503225]
[9]
Kulkarni, U.; Kulkarni, K.; Pardeshi, R.; Mane, D. High performance thin layer chromatographic detection of cannabis in forensic interest. J. Chem. Pharm. Res., 2018, 10(11), 9-14.
[10]
Kapur, B.M. Drug-testing methods and clinical interpretations of test results. Bull. Narc., 1993, 45(2), 115-154.
[PMID: 7920539]
[11]
Meatherall, R.C.; Garriott, J.C. A sensitive thin-layer chromatographic procedure for the detection of urinary 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid. J. Anal. Toxicol., 1988, 12(3), 136-140.
[http://dx.doi.org/10.1093/jat/12.3.136] [PMID: 2838684]
[12]
Zazoğlu, S.; Anilanmert, B.; Aydin, M.; Cengiz, S. Fast confirmation for marijuana metabolite: THC-COOH, ultra-fast LC—MS/MS run time, and application to routine samples. Acta Chromatogr., 2017, 29(2), 253-265.
[http://dx.doi.org/10.1556/1326.2017.29.2.09]
[13]
Parry, R.C.; Nolan, L.; Shirey, R.E.; Wachob, G.D.; Gisch, D.J. Pretreatment of urine samples for the analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid using solid-phase extraction. J. Anal. Toxicol., 1990, 14(1), 39-44.
[http://dx.doi.org/10.1093/jat/14.1.39] [PMID: 2156110]
[14]
Felli, M.; Martello, S.; Chiarotti, M. LC–MS–MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests. Forensic Sci. Int., 2011, 204(1-3), 67-73.
[http://dx.doi.org/10.1016/j.forsciint.2010.05.004] [PMID: 20627630]
[15]
Weinmann, W.; Vogt, S.; Goerke, R.; Müller, C.; Bromberger, A. Simultaneous determination of THC-COOH and THC-COOH-glucuronide in urine samples by LC/MS/MS. Forensic Sci. Int., 2000, 113(1-3), 381-387.
[http://dx.doi.org/10.1016/S0379-0738(00)00210-3] [PMID: 10978652]
[16]
Wahajuddin; Singh, S.P.; Jain, G.K. Determination of lumefantrine in rat plasma by liquid–liquid extraction using LC–MS/MS with electrospray ionization: Assay development, validation and application to a pharmacokinetic study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2009, 877(11-12), 1133-1139.
[http://dx.doi.org/10.1016/j.jchromb.2009.02.058] [PMID: 19285925]
[17]
Raising the game for clean sport. Available from: https://www.wada-ama.org (accessed on 8-10-2024)
[18]
Sahu, P.L.; Maurya, A.K.; Priyadarshini, S.; Siddiqui, A.A.; Sahu, K. Measurement uncertainty and validation for quantitation of salbutamol in human urine by gas chromatography-tandem mass spectrometry. J. Chromatogr. Sci., 2023, 61(7), 605-611.
[http://dx.doi.org/10.1093/chromsci/bmac079]
[19]
Bonini, S.A.; Premoli, M.; Tambaro, S.; Kumar, A.; Maccarinelli, G.; Memo, M.; Mastinu, A. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J. Ethnopharmacol., 2018, 227, 300-315.
[http://dx.doi.org/10.1016/j.jep.2018.09.004] [PMID: 30205181]
[20]
Rosendo, L.M.; Rosado, T.; Oliveira, P.; Simão, A.Y.; Margalho, C.; Costa, S.; Passarinha, L.A.; Barroso, M.; Gallardo, E. The determination of cannabinoids in urine samples using microextraction by packed sorbent and gas chromatography-mass spectrometry. Molecules, 2022, 27(17), 5503.
[http://dx.doi.org/10.3390/molecules27175503] [PMID: 36080271]
[21]
Reber, J.D.; Karschner, E.L.; Seither, J.Z.; Knittel, J.L.; Walterscheid, J.P. Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS. Clin. Biochem., 2021, 98, 54-62.
[http://dx.doi.org/10.1016/j.clinbiochem.2021.09.005] [PMID: 34529995]
[22]
Rumpler, M.J. Quantitative analysis of 11-nor-9-carboxy-tetrahydrocannbinol (THC–COOH) in urine by LC–MS/MS following a simple filtration. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2014, 957, 77-83.
[http://dx.doi.org/10.1016/j.jchromb.2014.02.056] [PMID: 24657414]
[23]
Sharma, P.; Rao, V.; Chand, P.K.; Murthy, P. Quantification of Δ9-tetrahydrocannabinol in urine as a marker of cannabis abuse. Indian J. Med. Res., 2023, 158(5&6), 535-541.
[http://dx.doi.org/10.4103/ijmr.IJMR_3899_20] [PMID: 37929356]
[24]
Gomes, R.L.; Meredith, W.; Snape, C.E.; Sephton, M.A. Analysis of conjugated steroid androgens: Deconjugation, derivatisation and associated issues. J. Pharm. Biomed. Anal., 2009, 49(5), 1133-1140.
[http://dx.doi.org/10.1016/j.jpba.2009.01.027] [PMID: 19304432]

© 2025 Bentham Science Publishers | Privacy Policy